Literature DB >> 11295996

Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study.

C DeCarli1, B L Miller, G E Swan, T Reed, P A Wolf, D Carmelli.   

Abstract

OBJECTIVE: To evaluate the relative risk (RR) of mild cognitive impairment (MCI) associated with cerebrovascular risk factors and cerebrovascular-related brain changes.
DESIGN: Mild cognitive impairment was determined for the subjects of the prospective National Heart, Lung, and Blood Institute Twin Study. Quantitative measures of brain, white matter hyperintensity, cerebral infarction, apolipoprotein E genotype, and psychometric testing were obtained.
RESULTS: Subjects with MCI were older (73.5 +/- 3.0 vs 72.1 +/- 2.8 years), consumed less alcohol (3.7 +/- 5.8 vs 7.0 +/- 10.7 drinks per week), had greater white matter hyperintensity volumes (0.56% +/- 0.82% vs 0.25% +/- 0.34% of cranial volume), and had an increased prevalence of apolipoprotein E4 genotype (31.4% vs 19.2%) than normal subjects. White matter hyperintensity and the presence of the apolipoprotein E4 genotype were associated with a significantly increased risk for MCI. When all subjects were included in the analysis, alcohol consumption was associated with a reduced risk for MCI (RR = 0.93, P<.05). When subjects with a history of symptomatic cerebrovascular disease were excluded from the analysis, elevated midlife diastolic blood pressure was associated with an increased risk for MCI (RR = 1.70, P<.05).
CONCLUSIONS: Elevated midlife blood pressures, and the resulting increased white matter hyperintensities, increase the risk for MCI in a group of community-dwelling older men to at least the same degree as apolipoprotein E4 genotype. Given the common occurrence of elevations in midlife blood pressure, early and effective treatment may be warranted to prevent late-life brain abnormalities and MCI. Moreover, since many individuals with MCI progress to clinical dementia, longitudinal evaluations of this cohort will be important.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11295996     DOI: 10.1001/archneur.58.4.643

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  89 in total

1.  White matter hyperintensity penumbra.

Authors:  Pauline Maillard; Evan Fletcher; Danielle Harvey; Owen Carmichael; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

2.  White matter hyperintensity and cognitive functioning in the racial and ethnic minority cohort of the Framingham Heart Study.

Authors:  Karina Stavitsky; Yangchun Du; Daniel Seichepine; Thomas M Laudate; Alexa Beiser; Sudha Seshadri; Charles Decarli; Philip A Wolf; Rhoda Au
Journal:  Neuroepidemiology       Date:  2010-06-15       Impact factor: 3.282

3.  Association between white matter microstructure, executive functions, and processing speed in older adults: the impact of vascular health.

Authors:  Heidi I L Jacobs; Elizabeth C Leritz; Victoria J Williams; Martin P J Van Boxtel; Wim van der Elst; Jelle Jolles; Frans R J Verhey; Regina E McGlinchey; William P Milberg; David H Salat
Journal:  Hum Brain Mapp       Date:  2011-09-23       Impact factor: 5.038

Review 4.  Clinical trials in mild cognitive impairment: lessons for the future.

Authors:  V Jelic; M Kivipelto; B Winblad
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-11-23       Impact factor: 10.154

5.  The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition.

Authors:  J He; V S S Wong; E Fletcher; P Maillard; D Y Lee; A-M Iosif; B Singh; O Martinez; A E Roach; S N Lockhart; L Beckett; D Mungas; S T Farias; O Carmichael; C DeCarli
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-26       Impact factor: 3.825

6.  Endothelial function and white matter hyperintensities in older adults with cardiovascular disease.

Authors:  Karin F Hoth; David F Tate; Athena Poppas; Daniel E Forman; John Gunstad; David J Moser; Robert H Paul; Angela L Jefferson; Andreana P Haley; Ronald A Cohen
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

Review 7.  Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease.

Authors:  F Portet; P J Ousset; P J Visser; G B Frisoni; F Nobili; Ph Scheltens; B Vellas; J Touchon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

Review 8.  Clinically asymptomatic vascular brain injury: a potent cause of cognitive impairment among older individuals.

Authors:  Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden.

Authors:  Charles DeCarli; Evan Fletcher; Vincent Ramey; Danielle Harvey; William J Jagust
Journal:  Stroke       Date:  2004-12-02       Impact factor: 7.914

10.  Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.

Authors:  Jing He; Sarah Farias; Oliver Martinez; Bruce Reed; Dan Mungas; Charles Decarli
Journal:  Arch Neurol       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.